Skip to main content
EU-Startups· David Cendon Garcia·· 17 hours agoTop DealsAI Score69

Commit Biologics raises €54M seed to advance cancer and autoimmune therapies

Denmark’s Commit Biologics secures €54 million Seed funding to advance cancer and autoimmune therapies

AI Overview

Copenhagen-based Commit Biologics raised €54 million ($60 million) in seed funding led by Ackermans & van Haaren.

Why it matters

Commit Biologics' €54M seed round shows investors backing a complement-based immunotherapy platform that works without T cells, a contrast to the T cell engagers and cell therapies that dominate the field.

Source:EU-Startups · eu-startups.com

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing